May 21, 2020 Regulators from around the world have agreed three priority areas for cooperation on observational research during COVID-19. They will collaborate on pregnancy research, on medicines used in clinical practice and on vaccine safety and effectiveness monitoring.…
Recent Post
- Best API Registration of Drugs in India
- What are CDSCO Form MD 26 and 27 and the benefits of having the import license for new medical devices?
- How To Get Wholesale Drug License in India?
- Loan Licensing in Pharmaceutical Manufacturing: Key Principles, Guidelines, and Regulatory Framework
- Safe Handling of Narcotic and Psychotropic Drugs in a Wholesale Warehouse: A Complete Guide